rs145689709
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The NM_001292063.2(OTOG):c.4022G>A(p.Arg1341Gln) variant causes a missense change. The variant allele was found at a frequency of 0.00349 in 1,550,594 control chromosomes in the GnomAD database, including 17 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R1341W) has been classified as Likely benign.
Frequency
Consequence
NM_001292063.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
OTOG | NM_001292063.2 | c.4022G>A | p.Arg1341Gln | missense_variant | 33/56 | ENST00000399397.6 | |
OTOG | NM_001277269.2 | c.4058G>A | p.Arg1353Gln | missense_variant | 32/55 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
OTOG | ENST00000399397.6 | c.4022G>A | p.Arg1341Gln | missense_variant | 33/56 | 5 | NM_001292063.2 | P2 | |
OTOG | ENST00000399391.7 | c.4058G>A | p.Arg1353Gln | missense_variant | 32/55 | 5 | A2 | ||
OTOG | ENST00000342528.2 | n.1360G>A | non_coding_transcript_exon_variant | 9/22 | 2 |
Frequencies
GnomAD3 genomes AF: 0.00284 AC: 433AN: 152228Hom.: 1 Cov.: 33
GnomAD3 exomes AF: 0.00242 AC: 360AN: 148718Hom.: 0 AF XY: 0.00255 AC XY: 204AN XY: 80130
GnomAD4 exome AF: 0.00356 AC: 4974AN: 1398248Hom.: 16 Cov.: 30 AF XY: 0.00345 AC XY: 2379AN XY: 689654
GnomAD4 genome AF: 0.00283 AC: 431AN: 152346Hom.: 1 Cov.: 33 AF XY: 0.00252 AC XY: 188AN XY: 74496
ClinVar
Submissions by phenotype
not provided Benign:3
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 07, 2024 | - - |
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Jul 14, 2021 | - - |
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | May 01, 2024 | OTOG: BP4, BS2 - |
Meniere disease Uncertain:1
Uncertain significance, criteria provided, single submitter | case-control | Otology & Neurotology- Genomics of vestibular disorders (CTS-495), Jose Antonio López Escámez, Centro Pfizer - Universidad de Granada - Junta de Andalucía de Genómica e Investigación Oncológica (GENYO) | Jan 01, 2020 | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Aug 24, 2015 | p.Arg1353Gln in exon 32 of OTOG: This variant is not expected to have clinical s ignificance because it has been identified in 0.56% (29/5214) of European chromo somes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs145689709). - |
OTOG-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Aug 18, 2020 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at